Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
PC 360
Article
Trump executive order presents challenges for workers’ comp, auto insurers
Workers' Comp
Article
Accelerating Recovery and Return to Work: The Case for Case Management
In workers’ compensation, one of the most effective ways to reduce claim duration and associated costs is to get injured employees back to work—saf
Workers' Comp
Article
Turning Regulatory Obstacles into Strategy Advantages Using Informed Decision-Making in Workers’ Comp & Auto Casualty
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in
WorkcompWire
Article
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Workers' Comp
Article
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
When a workplace injury disrupts an employee’s ability to work, the path back to productivity can be complex.
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp.